Nutr Res Pract.  2018 Jun;12(3):191-198. 10.4162/nrp.2018.12.3.191.

Comparison of the effect of three licorice varieties on cognitive improvement via an amelioration of neuroinflammation in lipopolysaccharide-induced mice

Affiliations
  • 1Department of Food Science and Nutrition, Pusan National University, 2 Busandaehak-ro 63 beon-gil, Geumjeong-gu, Busan 46241, Korea. ejcho@pusan.ac.kr
  • 2Department of Herbal Crop Research, NIHHS, RDA, Chungbuk 27709, Korea.

Abstract

BACKGROUND/OBJECTIVES
Neuroinflammation plays critical role in neurodegenerative disorders, such as Alzheimer's disease (AD). We investigated the effect of three licorice varieties, Glycyrhiza uralensis, G. glabra, and Shinwongam (SW) on a mouse model of inflammation-induced memory and cognitive deficit.
MATERIALS/METHODS
C57BL/6 mice were injected with lipopolysaccharide (LPS; 2.5 mg/kg, intraperitoneally) and orally administrated G. uralensis, G. glabra, and SW extract (150 mg/kg/day). SW, a new species of licorice in Korea, was combined with G. uralensis and G. glabra. Behavioral tests, including the T-maze, novel object recognition and Morris water maze, were carried out to assess learning and memory. In addition, the expressions of inflammation-related proteins in brain tissue were measured by western blotting.
RESULTS
There was a significant decrease in spatial and objective recognition memory in LPS-induced cognitive impairment group, as measured by the T-maze and novel object recognition test; however, the administration of licorice ameliorated these deficits. In addition, licorice-treated groups exhibited improved learning and memory ability in the Morris water maze. Furthermore, LPS-injected mice had up-regulated pro-inflammatory proteins, such as inducible nitric oxide synthase (iNOS), cyclooxygenase-2, interleukin-6, via activation of toll like receptor 4 (TLR4) and nuclear factor-kappa B (NFκB) pathways in the brain. However, these were attenuated by following administration of the three licorice varieties. Interestingly, the SW-administered group showed greater inhibition of iNOS and TLR4 when compared with the other licorice varieties. Furthermore, there was a significant increase in the expression of brain-derived neurotrophic factor (BDNF) in the brain of LPS-induced cognitively impaired mice that were administered licorice, with the greatest effect following SW treatment.
CONCLUSIONS
The three licorice varieties ameliorated the inflammation-induced cognitive dysfunction by down-regulating inflammatory proteins and up-regulating BDNF. These results suggest that licorice, in particular SW, could be potential therapeutic agents against cognitive impairment.

Keyword

BDNF; cognitive dysfunction; glycyrrhiza; Glycyrrhiza uralensis; inflammation

MeSH Terms

Alzheimer Disease
Animals
Behavior Rating Scale
Blotting, Western
Brain
Brain-Derived Neurotrophic Factor
Cognition Disorders
Cyclooxygenase 2
Glycyrrhiza uralensis
Glycyrrhiza*
Inflammation
Interleukin-6
Korea
Learning
Memory
Mice*
Neurodegenerative Diseases
Nitric Oxide Synthase Type II
Toll-Like Receptor 4
Water
Brain-Derived Neurotrophic Factor
Cyclooxygenase 2
Interleukin-6
Nitric Oxide Synthase Type II
Toll-Like Receptor 4
Water

Figure

  • Fig. 1 Experimental scheduleMice were orally administered with licorice extracts, including G. uralensis, G. glabra, and SW at concentration of 150 mg/kg/day for 7 days. 4 h prior to behavioral testing, mice received LPS injections (2.5 mg/kg/day, i.p., 3 times a week). LPS: Lipopolysaccharide

  • Fig. 2 The effects of licorice extracts on spatial memory, measured by the T-maze testData are presented as mean ± SD. * Means the space perception route cognitive abilities for familiar and novel routes are significantly different (P < 0.05) as determined by Student's t-test (n = 6 mice per group). Normal, 0.9% injection + oral administration of water; Control, LPS injection + oral administration of water; GU, LPS injection + oral administration G. uralensis (150 mg/kg/day); GB, LPS injection + oral administration G. glabra (150 mg/kg/day); SW, LPS injection + oral administration SW (150 mg/kg/day).

  • Fig. 3 The effects of licorice extracts on recognition memory in the novel object recognition testData are presented as mean ± SD. * Means of the space perception route cognitive abilities for familiar and novel routes are significantly different (P < 0.05) as determined by Student's t-test (n = 6 mice per group). Normal, 0.9% injection + oral administration of water; Control, LPS injection + oral administration of water; GU, LPS injection + oral administration G. uralensis (150 mg/kg/day); GB, LPS injection + oral administration G. glabra (150 mg/kg/day); SW, LPS injection + oral administration SW (150 mg/kg/day).

  • Fig. 4 The effects of licorice extracts on escape latency to the platform in the Morris water maze testData are presented as mean ± SD. a–b Means with different letters are significantly different (P < 0.05) as determined by Duncan's multiple tests (n = 6 mice per group). Normal, 0.9% injection + oral administration of water; Control, LPS injection + oral administration of water; GU, LPS injection + oral administration G. uralensis (150 mg/kg/day); GB, LPS injection + oral administration G. glabra (150 mg/kg/day); SW, LPS injection + oral administration SW (150 mg/kg/day).

  • Fig. 5 The effects of licorice extracts on escape latency to reach a hidden platform (A) and exposed platform (B) in the Morris water maze testData are presented as mean ± SD. a–b Means with different letters are significantly different (P < 0.05) as determined by Duncan's multiple tests. NS indicates no significant differences among experimental groups (n = 6 mice per group). Normal, 0.9% injection + oral administration of water; Control, LPS injection + oral administration of water; GU, LPS injection + oral administration G. uralensis (150 mg/kg/day); GB, LPS injection + oral administration G. glabra (150 mg/kg/day); SW, LPS injection + oral administration SW (150 mg/kg/day).

  • Fig. 6 The effects of licorice extracts on inflammation-related protein expressions including TLR4, NF-κB p65, iNOS and COX-2 in LPS-injected mice brainData are presented as mean ± SD. a–e Means with different letters are significantly different (P < 0.05) as determined by Duncan's multiple tests. Normal, 0.9% injection + oral administration of water; Control, LPS injection + oral administration of water; GU, LPS injection + oral administration G. uralensis (150 mg/kg/day); GB, LPS injection + oral administration G. glabra (150 mg/kg/day); SW, LPS injection + oral administration SW (150 mg/kg/day).

  • Fig. 7 The effects of licorice extracts on IL-6 protein expressions in LPS-injected mice brainData are presented as mean ± SD. a–e Means with different letters are significantly different (P < 0.05) as determined by Duncan's multiple tests. Normal, 0.9% injection + oral administration of water; Control, LPS injection + oral administration of water; GU, LPS injection + oral administration G. uralensis (150 mg/kg/day); GB, LPS injection + oral administration G. glabra (150 mg/kg/day); SW, LPS injection + oral administration SW (150 mg/kg/day).

  • Fig. 8 The effects of licorice extracts on BDNF protein expressions in LPS-injected mice brainData are presented as mean ± SD. a–e Means with different letters are significantly different (P < 0.05) as determined by Duncan's multiple tests. Normal, 0.9% injection + oral administration of water; Control, LPS injection + oral administration of water; GU, LPS injection + oral administration G. uralensis (150 mg/kg/day); GB, LPS injection + oral administration G. glabra (150 mg/kg/day); SW, LPS injection + oral administration SW (150 mg/kg/day).


Reference

1. Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM. Forecasting the global burden of Alzheimer's disease. Alzheimers Dement. 2007; 3:186–191. PMID: 19595937.
Article
2. Price JL, Morris JC. Tangles and plaques in nondemented aging and “preclinical” Alzheimer's disease. Ann Neurol. 1999; 45:358–368. PMID: 10072051.
Article
3. Butterfield DA. Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review. Free Radic Res. 2002; 36:1307–1313. PMID: 12607822.
4. Canevari L, Abramov AY, Duchen MR. Toxicity of amyloid beta peptide: tales of calcium, mitochondria, and oxidative stress. Neurochem Res. 2004; 29:637–650. PMID: 15038611.
5. Butterfield DA, Griffin S, Munch G, Pasinetti GM. Amyloid beta-peptide and amyloid pathology are central to the oxidative stress and inflammatory cascades under which Alzheimer's disease brain exists. J Alzheimers Dis. 2002; 4:193–201. PMID: 12226538.
6. DeLegge MH, Smoke A. Neurodegeneration and inflammation. Nutr Clin Pract. 2008; 23:35–41. PMID: 18203962.
Article
7. Saijo K, Winner B, Carson CT, Collier JG, Boyer L, Rosenfeld MG, Gage FH, Glass CK. A Nurr1/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death. Cell. 2009; 137:47–59. PMID: 19345186.
Article
8. Lukiw WJ. Bacteroides fragilis lipopolysaccharide and inflammatory signaling in Alzheimer's disease. Front Microbiol. 2016; 7:1544. PMID: 27725817.
Article
9. Qin L, Wu X, Block ML, Liu Y, Breese GR, Hong JS, Knapp DJ, Crews FT. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia. 2007; 55:453–462. PMID: 17203472.
Article
10. Rosi S, Vazdarjanova A, Ramirez-Amaya V, Worley PF, Barnes CA, Wenk GL. Memantine protects against LPS-induced neuroinflammation, restores behaviorally-induced gene expression and spatial learning in the rat. Neuroscience. 2006; 142:1303–1315. PMID: 16989956.
Article
11. Hanke ML, Kielian T. Toll-like receptors in health and disease in the brain: mechanisms and therapeutic potential. Clin Sci (Lond). 2011; 121:367–387. PMID: 21745188.
Article
12. Café-Mendes CC, Garay-Malpartida HM, Malta MB, de Sá Lima L, Scavone C, Ferreira ZS, Markus RP, Marcourakis T. Chronic nicotine treatment decreases LPS signaling through NF-κB and TLR-4 modulation in the hippocampus. Neurosci Lett. 2017; 636:218–224. PMID: 27984197.
Article
13. Ray B, Lahiri DK. Neuroinflammation in Alzheimer's disease: different molecular targets and potential therapeutic agents including curcumin. Curr Opin Pharmacol. 2009; 9:434–444. PMID: 19656726.
Article
14. Jain NK, Patil CS, Kulkarni SK, Singh A. Modulatory role of cyclooxygenase inhibitors in aging- and scopolamine or lipopolysaccharide-induced cognitive dysfunction in mice. Behav Brain Res. 2002; 133:369–376. PMID: 12110471.
Article
15. Liao WC, Lin YH, Chang TM, Huang WY. Identification of two licorice species, Glycyrrhiza uralensis and Glycyrrhiza glabra, based on separation and identification of their bioactive components. Food Chem. 2012; 132:2188–2193.
Article
16. Hosseinzadeh H, Nassiri-Asl M. Pharmacological effects of Glycyrrhiza spp. and its bioactive constituents: update and review. Phytother Res. 2015; 29:1868–1886. PMID: 26462981.
17. Yang R, Yuan BC, Ma YS, Zhou S, Liu Y. The anti-inflammatory activity of licorice, a widely used Chinese herb. Pharm Biol. 2017; 55:5–18. PMID: 27650551.
Article
18. Barfod L, Kemp K, Hansen M, Kharazmi A. Chalcones from Chinese liquorice inhibit proliferation of T cells and production of cytokines. Int Immunopharmacol. 2002; 2:545–555. PMID: 11962733.
Article
19. Yo YT, Shieh GS, Hsu KF, Wu CL, Shiau AL. Licorice and licochalcone-A induce autophagy in LNCaP prostate cancer cells by suppression of Bcl-2 expression and the mTOR pathway. J Agric Food Chem. 2009; 57:8266–8273. PMID: 19711916.
Article
20. Lee HK, Yang EJ, Kim JY, Song KS, Seong YH. Inhibitory effects of Glycyrrhizae radix and its active component, isoliquiritigenin, on Aβ(25-35)-induced neurotoxicity in cultured rat cortical neurons. Arch Pharm Res. 2012; 35:897–904. PMID: 22644857.
Article
21. Nomura T, Fukai T. Phenolic constituents of licorice (Glycyrrhiza species). Fortschr Chem Org Naturst. 1998; 73:1–158. PMID: 9545874.
Article
22. Ojha S, Javed H, Azimullah S, Abul Khair SB, Haque ME. Glycyrrhizic acid attenuates neuroinflammation and oxidative stress in rotenone model of Parkinson's disease. Neurotox Res. 2016; 29:275–287. PMID: 26607911.
Article
23. Cherng JM, Lin HJ, Hung MS, Lin YR, Chan MH, Lin JC. Inhibition of nuclear factor κB is associated with neuroprotective effects of glycyrrhizic acid on glutamate-induced excitotoxicity in primary neurons. Eur J Pharmacol. 2006; 547:10–21. PMID: 16952351.
Article
24. Song JH, Lee JW, Shim B, Lee CY, Choi S, Kang C, Sohn NW, Shin JW. Glycyrrhizin alleviates neuroinflammation and memory deficit induced by systemic lipopolysaccharide treatment in mice. Molecules. 2013; 18:15788–15803. PMID: 24352029.
Article
25. Akman T, Guven M, Aras AB, Ozkan A, Sen HM, Okuyucu A, Kalkan Y, Sehitoglu I, Silan C, Cosar M. The neuroprotective effect of glycyrrhizic acid on an experimental model of focal cerebral ischemia in rats. Inflammation. 2015; 38:1581–1588. PMID: 25687639.
Article
26. Guo J, Yang CX, Yang JJ, Yao Y. Glycyrrhizic acid ameliorates cognitive impairment in a rat model of vascular dementia associated with oxidative damage and inhibition of voltage-gated sodium channels. CNS Neurol Disord Drug Targets. 2016; 15:1001–1008. PMID: 27238153.
27. National Institute of Horticultural and Herbal Science (KR). 2014 Annual Reports. Wanju: National Institute of Horticultural and Herbal Science;2014. p. 58–59.
28. Wang X, Zhang H, Chen L, Shan L, Fan G, Gao X. Liquorice, a unique “guide drug” of traditional Chinese medicine: a review of its role in drug interactions. J Ethnopharmacol. 2013; 150:781–790. PMID: 24201019.
Article
29. Lee JW, Lee YK, Yuk DY, Choi DY, Ban SB, Oh KW, Hong JT. Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of beta-amyloid generation. J Neuroinflammation. 2008; 5:37. PMID: 18759972.
Article
30. Gu SM, Park MH, Hwang CJ, Song HS, Lee US, Han SB, Oh KW, Ham YW, Song MJ, Son DJ, Hong JT. Bee venom ameliorates lipopolysaccharide-induced memory loss by preventing NF-kappaB pathway. J Neuroinflammation. 2015; 12:124. PMID: 26112466.
Article
31. Montgomery KC. A test of two explanations of spontaneous alternation. J Comp Physiol Psychol. 1952; 45:287–293. PMID: 14946277.
Article
32. Bevins RA, Besheer J. Object recognition in rats and mice: a one-trial non-matching-to-sample learning task to study ‘recognition memory’. Nat Protoc. 2006; 1:1306–1311. PMID: 17406415.
Article
33. Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods. 1984; 11:47–60. PMID: 6471907.
Article
34. Montgomery KC. Exploratory behavior and its relation to spontaneous alternation in a series of maze exposures. J Comp Physiol Psychol. 1952; 45:50–57. PMID: 14907933.
Article
35. Lee YJ, Choi DY, Choi IS, Kim KH, Kim YH, Kim HM, Lee K, Cho WG, Jung JK, Han SB, Han JY, Nam SY, Yun YW, Jeong JH, Oh KW, Hong JT. Inhibitory effect of 4-O-methylhonokiol on lipopolysaccharide-induced neuroinflammation, amyloidogenesis and memory impairment via inhibition of nuclear factor-kappaB in vitro and in vivo models. J Neuroinflammation. 2012; 9:35. PMID: 22339795.
Article
36. Miwa M, Tsuboi M, Noguchi Y, Enokishima A, Nabeshima T, Hiramatsu M. Effects of betaine on lipopolysaccharide-induced memory impairment in mice and the involvement of GABA transporter 2. J Neuroinflammation. 2011; 8:153. PMID: 22053950.
Article
37. Sparkman NL, Martin LA, Calvert WS, Boehm GW. Effects of intraperitoneal lipopolysaccharide on Morris maze performance in year-old and 2-month-old female C57BL/6J mice. Behav Brain Res. 2005; 159:145–151. PMID: 15795008.
Article
38. Sharifzadeh M, Shamsa F, Shiran S, Karimfar MH, Miri AH, Jalalizadeh H, Gholizadeh S, Salar F, Tabrizian K. A time course analysis of systemic administration of aqueous licorice extract on spatial memory retention in rats. Planta Med. 2008; 74:485–490. PMID: 18404595.
Article
39. Dhingra D, Parle M, Kulkarni SK. Memory enhancing activity of Glycyrrhiza glabra in mice. J Ethnopharmacol. 2004; 91:361–365. PMID: 15120462.
Article
40. Rubio-Perez JM, Morillas-Ruiz JM. A review: inflammatory process in Alzheimer's disease, role of cytokines. ScientificWorldJournal. 2012; 2012:756357. PMID: 22566778.
Article
41. Borowski T, Kokkinidis L, Merali Z, Anisman H. Lipopolysaccharide, central in vivo biogenic amine variations, and anhedonia. Neuroreport. 1998; 9:3797–3801. PMID: 9875707.
Article
42. Lukiw WJ, Bazan NG. Strong nuclear factor-kappaB-DNA binding parallels cyclooxygenase-2 gene transcription in aging and in sporadic Alzheimer's disease superior temporal lobe neocortex. J Neurosci Res. 1998; 53:583–592. PMID: 9726429.
43. Thiyagarajan P, Chandrasekaran CV, Deepak HB, Agarwal A. Modulation of lipopolysaccharide-induced pro-inflammatory mediators by an extract of Glycyrrhiza glabra and its phytoconstituents. Inflammopharmacology. 2011; 19:235–241. PMID: 21328091.
Article
44. Wu TY, Khor TO, Saw CL, Loh SC, Chen AI, Lim SS, Park JH, Cai L, Kong AN. Anti-inflammatory/Anti-oxidative stress activities and differential regulation of Nrf2-mediated genes by non-polar fractions of tea Chrysanthemum zawadskii and licorice Glycyrrhiza uralensis. AAPS J. 2011; 13:1–13. PMID: 20967519.
Article
45. Schröfelbauer B, Raffetseder J, Hauner M, Wolkerstorfer A, Ernst W, Szolar OH. Glycyrrhizin, the main active compound in liquorice, attenuates pro-inflammatory responses by interfering with membrane-dependent receptor signalling. Biochem J. 2009; 421:473–482. PMID: 19442240.
Article
46. Yu JY, Ha JY, Kim KM, Jung YS, Jung JC, Oh S. Anti-Inflammatory activities of licorice extract and its active compounds, glycyrrhizic acid, liquiritin and liquiritigenin, in BV2 cells and mice liver. Molecules. 2015; 20:13041–13054. PMID: 26205049.
47. Bekinschtein P, Cammarota M, Katche C, Slipczuk L, Rossato JI, Goldin A, Izquierdo I, Medina JH. BDNF is essential to promote persistence of long-term memory storage. Proc Natl Acad Sci U S A. 2008; 105:2711–2716. PMID: 18263738.
Article
48. Saura CA, Valero J. The role of CREB signaling in Alzheimer's disease and other cognitive disorders. Rev Neurosci. 2011; 22:153–169. PMID: 21476939.
Article
49. Song JH, Yu JT, Tan L. Brain-derived neurotrophic factor in Alzheimer's disease: risk, mechanisms, and therapy. Mol Neurobiol. 2015; 52:1477–1493. PMID: 25354497.
Article
50. Schnydrig S, Korner L, Landweer S, Ernst B, Walker G, Otten U, Kunz D. Peripheral lipopolysaccharide administration transiently affects expression of brain-derived neurotrophic factor, corticotropin and proopiomelanocortin in mouse brain. Neurosci Lett. 2007; 429:69–73. PMID: 17976910.
Article
Full Text Links
  • NRP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr